“glaxosmithkline” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs 05/28/20 Seattle
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine 05/01/20 Europe
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
GSK and Sanofi Team Up on COVID-19 Vaccine, Aim for Clinic This Year 04/14/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
Page 1 of 24 next page »